About BioGenix
Science, transparency, and enduring relationships with clinicians guide our work.
BioGenix is the World's Leading Regenerative Therapy Company
BioGenix grew out of the recognition that regenerative medicine presents hope to patients who suffer from diseases or injuries. Regenerative medicine is expected to play a pivotal role within the healthcare industry. BioGenix has a longstanding reputation for building and maintaining supportive relationships with clinicians.
Realizing the intrinsic value of transparency, BioGenix is committed to consistently sharing cutting-edge studies about innovative therapies and life science principles that support the natural healing of the body. We are equally committed to providing high-quality allograft products to clinicians all over the world.
Our commitment to excellence serves as the foundation of our core operating ethos, culminating in the best safety track record within the industry. BioGenix adheres to stringent guidelines under Current Good Manufacturing Practices (cGMP), Current Good Tissue Practice (cGTP), state regulations, AATB guidelines, and FDA requirements for Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps).